D D Schoepp - Concepedia

Author

D D Schoepp

Also Known As

D D Schoepp, D. D. SCHOEPP, D. D. Schoepp, D. Schoepp, D.D Schoepp, D.D. Schoepp, Darryl D. Schoepp, Darryl Schoepp, Darryle D. Schoepp

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)University of Bristol

About

D D Schoepp is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	444
2	Social Sciences	2	2	225
3	Biochemistry	2	2	94
4	Health Sciences	1	1	12
5	Cellular Physiology	1	1	12

D D Schoepp

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Unveiling the Functions of Presynaptic Metabotropic Glutamate Receptors in the Central Nervous System D D Schoepp Journal of Pharmacology and Experimental Therapeutics	2001	688
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity Stephen M. Fitzjohn, Zuner A. Bortolotto, Mary J. Palmer, Neuropharmacology Synaptic PlasticityG Protein-coupled ReceptorMedicineNovel Mglu ReceptorsFunctional Selectivity	1998	161
Preparative methods for brain slices: a discussion Peter G. Aitken, George R. Breese, F.F. Dudek, Journal of Neuroscience Methods Preparative MethodsNeuroimaging ModalityMedicineBrain MappingNeuroimaging	1995	151
[3H]LY341495 Binding to Group II Metabotropic Glutamate Receptors in Rat Brain Rebecca A. Wright, M. Brian Arnold, William J. Wheeler, Journal of Pharmacology and Experimental Therapeutics	2001	99
Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat. Aida Sacaan, JA Monn, D D Schoepp Journal of Pharmacology and Experimental Therapeutics	1991	85
4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action Paul L. Ornstein, D D Schoepp, M. Brian Arnold, Journal of Medicinal Chemistry	1991	85
A novel, competitive mGlu<sub>5</sub> receptor antagonist (LY344545) blocks DHPG‐induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices Andrew J. Doherty, Mary J. Palmer, Z A Bortolotto, British Journal of Pharmacology Synaptic TransmissionReceptor Antagonist ActivityPharmacotherapyExperimental PharmacologySynaptic Signaling	2000	74
The Metabotropic Glutamate (mGLU)2/3 Receptor Antagonist LY341495 [2 S-2-Amino-2-(1 S,2 S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic Acid] Stimulates Waking and Fast Electroencephalogram Power and Blocks the Effects of the mGLU2/3 Receptor Agonist LY379268 [(-)-2-Oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in Rats Irwin Feinberg, D D Schoepp, K.-C. Hsieh, Journal of Pharmacology and Experimental Therapeutics	2005	40
Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists. Manisha Desai, J. Paul Burnett, Paul L. Ornstein, Journal of Pharmacology and Experimental Therapeutics	1995	37
Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495 A. Linden, Bryan G. Johnson, Nina Trokovic, Neuropharmacology Molecular PhysiologyFunctional SelectivityMedicineG Protein-coupled ReceptorImmunology	2009	26

Page 1